Archives20242023202220212020201920182017201620152014201320122011 August 13, 2013UPDATE: Cancer Programme IPP-204106 Read More August 12, 2013FDA Grants ImmuPharma ammended SPA for Lupuzor Phase III; Company Progresses Development Activities Read More July 08, 2013Appointment of Scientific Advisory Board Read More May 21, 2013ImmuPharma secures £50M financing facility for Lupuzor Phase III Read More April 08, 2013Immupharma gets Lupuzor research boost Read More February 28, 2013ImmuPharma Commences Trading on the Stuttgart Stock Exchange Read More January 28, 2013CNRS Confirms Lupuzor’sTM Effectiveness Read More
August 12, 2013FDA Grants ImmuPharma ammended SPA for Lupuzor Phase III; Company Progresses Development Activities Read More
